Skip to main content
OpenTrials
Completed

NCT Number: NCT00825396

An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

The purpose of this study is to determine the safety and tolerability of topical C-KAD Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ocular Hypertension Eye Diseases

Age range

50 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Charlotte Eye, Ear, Nose & Throat Associates

Charlotte, North Carolina, 28210, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both eyes having intraocular pressure in the range of 22-30 mmHg at baseline
  • Both eyes having best corrected visual acuity better than 20/50

Exclusion criteria

  • Advanced glaucoma
  • Closed or barely open anterior chamber or history of angle closure

Treatment and study plan

C-KAD Ophthalmic Solution

Drug

4 drops applied daily for 150 days

Primary outcomes

  1. Mean change in intraocular pressure from baseline

    Time frame: 150 Days

Sponsors and collaborators

Lead sponsor

Chakshu Research, Inc.

Industry

Registry information

Official study title

A Pilot, Open-Label, Controlled Clinical Trial of C-KAD Ophthalmic Solution in Reducing Intraocular Pressure in Patients With Ocular Hypertension

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Jan 21, 2009
Registry last updated
Jun 11, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.